Evidence map›Paper›PMID 42191567›Full record

ArticleDrug testing and analysis2026

Exploring Cerumen as an Alternative Matrix for Drug Detection and Quantification: Method Development and Application in Clinical Samples.

Dimitrios Phaedon Kevrekidis, Helen G Gika, Georgios Panagiotoglou, Eleni Parlapani, Pavlos Pavlidis, Nikolaos Raikos

Abstract read
In one paragraph

Article in Drug testing and analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dimitrios Phaedon KevrekidisLaboratory of Forensic Medicine and Toxicology, Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID https://orcid.org/0000-0001-8971-3557
Helen G GikaLaboratory of Forensic Medicine and Toxicology, Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Georgios PanagiotoglouPsychiatric Clinic "Agia Irini", Drama, Greece.
Eleni Parlapani1st Department of Psychiatry, General Hospital "Papageorgiou", Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Pavlos PavlidisLaboratory of Forensic Medicine and Toxicology, Department of Medicine, Democritus University of Thrace, Komotini, Greece.
Nikolaos RaikosLaboratory of Forensic Medicine and Toxicology, Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerumen (earwax) is a complex mix of apocrine and holocrine secretions and skin cells. In recent years, it has emerged as an innovative specimen for the detection of xenobiotics, suggesting that it has both clinical and forensic applications. An LC-MS/MS method was developed for the detection of 33 psychoactive medications in cerumen and urine and applied to samples from 60 psychiatric inpatient volunteers. The history of administration and qualitative results between urine and cerumen were generally consistent, with haloperidol, quetiapine, and nebivolol being detected more frequently in cerumen. In certain cases, drugs were detected both with very recent and without any recent administration, even when they were not in urine, highlighting opportunities for utilization in monitoring both acute and chronic administration and even following the cessation of administration. However, no clear relationship was found between drug concentrations and time of administration or total daily dose in most cases, consistent with challenges of routine collection. Cerumen concentrations were higher among more hydrophilic drugs with lower molecular weight and protein binding and demonstrated the best fit with an inverse regression model. No relationship was found with patient sex. Our results suggest that the disposition of drugs in cerumen is complex, being downstream of insufficiently elucidated pathways through migrating skin cells, ceruminous, and sebaceous glands. The present study is the first to investigate the routine collection of cerumen in a clinical setting and has broad implications for the interpretation of drug testing results with this emerging alternative biological specimen.

Indexed as

CerumenPsychotropic DrugsSubstance Abuse DetectionAdultFemaleHumansLiquid Chromatography-Mass SpectrometryMaleTandem Mass SpectrometryPsychotropic Drugsalternative biological matrixapocrine sweatclinical drug testingearwaxtherapeutic drug monitoring

Identifiers

PMID42191567
PMCPMC13432721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.